PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$35.15
+1.36% today
Updated 2026-09-22
Market cap
$1.43B
P/E ratio
14.46
P/S ratio
0.94x
EPS (TTM)
$2.43
Dividend yield
1.38%
52W range
$28 – $60
Volume
0.2M
Phibro Animal Health Corporation (PAHC) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$35.15
12-Month target
$71.25
2030 Target
—
Intrinsic (DCF)
$46.99
Financial forecast
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $0.9B | $1.0B | $1.0B | $1.3B | $1.5B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 14.46x (capped 25x) · Margin: 6.57%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.